|Articles|May 1, 2001
- Pharmaceutical Executive-05-01-2001
- Volume 0
- Issue 0
The Next Y2K
Author(s)Mark E. Kolb
Companies Face Costly System Overhauls With New FDA Regulations
Advertisement
Articles in this issue
about 25 years ago
Policy: Task Mastersabout 25 years ago
Pharmacia's Carrie Cox: HBA Woman of the Yearabout 25 years ago
Friends of Complexityabout 25 years ago
Under Federal Fireabout 25 years ago
Task Force: Enter the Fixersabout 25 years ago
Political ScienceAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5